Money
Filter News
Found 59,525 articles
-
Biotechnology company Morphic Therapeutic has just publicized their completion of a successful $80 million Series B financing meant to support their two lead programs in developing modern oral integrin therapies, as well as further other clinic programs.
-
Pharma Companies React to Employers and Health Plans Excluding New Therapies Based on Cost
9/25/2018
Recently, a few companies and government programs have decided to enact their own plans that they believe will help bring down the cost of new therapies. Pharmaceutical companies have begun asserting their positions on the topic. -
agilon health Achieves 20 Percent Boost In Closing Care Gaps By Using Physician And Member Incentives For Preventive Care
9/25/2018
Company releases its Annual Quality Outcomes Report
-
Orphan Star Therapeutics Announces Initial Financing and Corporate Update
9/25/2018
Orphan Star Therapeutics, LLC today announced it has successfully secured a commitment of $20 million from a commercial pharmaceutical partner.
-
Oragenics, Inc. to Present at Upcoming Conferences in October
9/25/2018
Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced it will present and meet with investors at The MicroCap Conference on October 1, 2018, at 1:00 PM ET as part of Track 1 at The Essex House in New York City.
-
MindBeacon closes Series A funding to propel growth for digital mental health platform
9/25/2018
MindBeacon Group today announced the closing of a Series A investment bringing total investment to over $20 million, with participation from TELUS Ventures, Manulife, Elkland Capital, Strauss Interests, and several prominent private investors.
-
Holmusk Raises US$9.75 Million in Pre-Series A Financing
9/25/2018
Holmusk today announced closing of US$9.75 million in Pre-Series A financing. The financing round included funding from Heritas Venture Fund as well as participation from new and existing investors. The funds allow Holmusk to expand its footprint in USA and Europe.
-
Ceribell Announces Completion Of $35 Million Series B Financing
9/25/2018
Proceeds will be used to expand commercialization of its innovative Rapid Response EEG System to improve the diagnosis and treatment of patients at risk for seizures
-
According to BioPharm Catalyst there were, or soon will be, 58 biopharma IPOs in 2018. And the trend doesn’t appear to be slowing. Here’s a look at five upcoming biotech IPOs.
-
National Institutes of Health Names CHOP, Penn an Undiagnosed Diseases Network Site
9/24/2018
The National Institute of Health (NIH) has named Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania (HUP) as one of the newest sites of its Undiagnosed Diseases Network (UDN), awarding the two institutions $2.5 million in research grants.
-
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
9/24/2018
The Food and Drug Administration (FDA) today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases.
-
OSF Ventures Expands Support in Company Addressing Heart Failure Management
9/24/2018
OSF Ventures, the corporate investment arm of OSF HealthCare, was part of an investor syndicate helping medtech company, Endotronix, Inc., close a $45 million Series D round of financing.
-
Data Projects the Global Cannabis Market is Projected to Reach USD 31.4 Billion by 2012
9/24/2018
According to data published by Forbes, citing Brightfield Group, the global cannabis market is projected to reach USD 31.4 Billion by 2021. By end of 2017, the global cannabis market value was estimated at USD 7.7 Billion, in which the U.S. held about 90% of total sales.
-
William Lautman, Managing Partner of Nexus Health Capital Donates $1.5 Million to Smile Train to Expand Multi-Year Partnership to Bring Forever Smiles to Children in Argentina
9/24/2018
William Lautman, Managing Partner of Nexus Health Capital, a New York and Dallas-based Healthcare Investment Bank, today announced a one million dollar planned gift in addition to five hundred thousand dollars donated to Smile Train in order to bring forever smiles to children with clefts in Argentina and around the world.
-
Magenta Therapeutics Added to Russell 2000 and 3000 Indexes
9/24/2018
The Russell 3000 index includes the 3,000 largest U.S. companies by market capitalization.
-
RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment
9/24/2018
YOFOTO (China) Health and RepliCel Life Sciences now cleared to close investment transaction and commence collaboration activity in Greater China
-
Cannabics Pharmaceuticals Inc. Prices $7,500,000 Registered Direct Offering
9/24/2018
CANNABICS PHARMACEUTICALS INC. (OTCQB: CNBX) ("Cannabics" or the "Company"), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced it has entered into definitive agreements with investors for the purchase and sale of (i) 10,000,000 shares of common stock,
-
Blueprint Healthcare Real Estate Advisors Celebrates 5 Years and Surpasses $3.5 Billion in Transaction Volume
9/24/2018
During the last five years, the firm has structured over 200 transactions with an aggregate sale value of over $3.5 billion.
-
Global Intragastric Balloons Market 2018-2022 | 25% CAGR Projection Over the Next Four Years | Technavio
9/24/2018
The global intragastric balloons market 2018-2022 is expected to post a CAGR of more than 25% during the forecast period, according to the latest market research report by Technavio.
-
Global Gene Therapy Market 2018-2022| 22% CAGR Projection Over the Next Four Years | Technavio
9/24/2018
Technavio analysts forecast the global gene therapy market to grow at a CAGR of over 22% during the forecast period, according to their latest market research report.